Pursuing a precision paradigm

Pursuing a precision paradigm

Why move from current standards of patient care to a more personalized approach to treatment? Experts at the School of Medicine describe today’s medical landscape as they plan for the care — and cures — of the future.
Undaunted explorer

Undaunted explorer

Timothy Ley, MD, has been investigating leukemia, particularly acute myeloid leukemia (AML), for decades. His research team now knows the mutations they need to go after ­aggressively, the nature of the ­mutations that need to be targeted and why patients relapse.
A promising future

A promising future

At Washington University, training the next generation of leaders in translational medicine is a key focus. Here, Cheryl Leyns and Phat Huynh share stories of working in the lab of David Holtzman, MD, researching pathologies of Alzheimer’s disease.